May. 21 at 8:34 PM
$CRIS In truth, there are a number of big pharma that would like to use CRIS drug WITH THEIR CANCER DRUG to renew the patients that are no longer responding to their drugs. It seems to work for this, and that means longer term patients once they are back on the drugs. This is a big win, since many patients would die in a few weeks if not given the CRIS drug. We just need to finish the trials ASAP. Get approval in one indication, with one pharma oncology drug, and it can immediately be prescribed off label, in deals with all the other pharma.
I bought this a while back, thinking, how long could it take to prove that an oncology drug for a disease that kills patients in a few weeks works??? I really do not understand why, if we can find even 3 patients that take it and respond by surviving just 3 months, you know darned well that is NOT due to chance alone. Why are these trials taking so long? I understand there are few patients, but it ONLY TAKES a few. Yes, I understand stats.
